December 23, 2008 – The Society of Nuclear Medicine (SNM) will hold its annual Mid-Winter Educational Symposium February 5-8 at the Hilton Clearwater in Clearwater, FL.
This year SNM, the American College of Nuclear Physicians (ACNP) and the American College of Nuclear Medicine (ACNM) unite to create a fused meeting, offering attendees the opportunity to earn up to 31.25 credits. The symposium is designed for nuclear medicine physicians, technologists, radiologists, cardiologists, pharmacists and other professionals who are involved and interested in current and emerging technical and clinical applications of nuclear medicine and molecular imaging and therapy.
At this year's program, participants will examine the increasingly important role of radiopharmaceuticals in targeting therapy. Attendees will also discuss recent advances in cardiovascular molecular imaging and how these procedures are being used to detect and treat heart disease and investigate how molecular imaging tools are used to effectively evaluate the precise location of disease and individualize patient care.
The mid-winter meeting will be followed by a special workshop, February 8–9, 2009, about the SNM Clinical Trials Network. At this workshop, participants will learn how this new network will facilitate drug development and speed the development, utilization and approval of both imaging biomarkers and diagnostic molecular imaging agents.
SNM's 56th Annual Meeting will take place June 13–17 2009, in Toronto, Canada.
For more information: www.snm.org